Kunming Longjin Pharmaceutical Co., Ltd.

Shenzhen Stock Exchange 002750.SZ

Kunming Longjin Pharmaceutical Co., Ltd. Free Cash Flow for the year ending December 31, 2023: USD -7.74 M

Kunming Longjin Pharmaceutical Co., Ltd. Free Cash Flow is USD -7.74 M for the year ending December 31, 2023, a -34.60% change year over year. Free cash flow is the amount of cash a company generates after accounting for cash outflows to support operations and maintain its capital assets.

Kunming Longjin Pharmaceutical Co., Ltd. Free Cash Flow for the year ending December 31, 2022 was USD -5.75 M, a -45.18% change year over year.
Kunming Longjin Pharmaceutical Co., Ltd. Free Cash Flow for the year ending December 31, 2021 was USD -3.96 M, a 14.96% change year over year.
Kunming Longjin Pharmaceutical Co., Ltd. Free Cash Flow for the year ending December 31, 2020 was USD -4.66 M, a -969.79% change year over year.
Kunming Longjin Pharmaceutical Co., Ltd. Free Cash Flow for the year ending December 31, 2019 was USD -435.15 K, a -118.51% change year over year.

Key data

Date	Free Cash Flow	Operating Cash Flow	Net Cash Used For Investing Activities	Net Cash Used Provided By Financing Activities

Shenzhen Stock Exchange: 002750.SZ

Kunming Longjin Pharmaceutical Co., Ltd.

CEO	Mr. Ya He Li
IPO Date	March 24, 2015
Location	China
Headquarters	NO.789, Lanmao Road
Employees	285
Sector	Health Care
Industries Pharmaceuticals Paper & Forest Products

Description

Kunmig Longjin Pharmaceutical Co., Ltd. develops, produces, and sells natural botanicals and chemical freeze-dried powder injections in China. The company offers Chinese, biochemical, chemical, cardio-cerebral vascular, and digestive system medicines; immune system and first aid medications; and vitamins, minerals, and enteral and parenteral nutrition products. It also engages in the industrial hemp plantation business. The company was founded in 1996 and is headquartered in Kunming, China.

Key trends

Past 5 years